Colorectal Cancer
Trial Solutions

Enhancing study success with advanced clinical research technologies and expert solutions for Colorectal Cancer trials.

DOWNLOAD BROCHURE GET IN TOUCH

Reduce Study Participation Burdens
Leverage the Power of PRO Data
Optimize Supply Management
Improve Patient Adherence

Reduce Study Participation Burdens

Reduce Study Participation Burdens

Sponsors and CROs leverage our eConsent and Telemedicine solutions as convenient tools to simplify the consent process, ensure up-to-date ICFs, and check in with patients more frequently via remote video visits. These tools also reduce burdens for patients who may not feel well enough to travel to a site.
Leverage the Power of PRO Data

Leverage the Power of PRO Data

A vital component for any global oncology study, our robust eCOA platform includes dozens of pre-validated oncology measures as well as common study design templates to expedite study startup. Plus, take advantage of our clinical and eCOA science expertise to leverage patient-reported outcome measures in support of endpoints and in accordance with recent regulatory guidance.
Optimize Supply Management

Optimize Supply Management

Signant's RTSM platform can streamline workflows for complex protocol designs. Our proprietary algorithms adapt seamlessly to cohort assignment, optimize drug supplies to reduce waste, and accommodate multiple treatment arms and administration cycles.
Improve Patient Adherence

Improve Patient Adherence

Built into our eCOA patient app, engagement features provide appointment reminders, notifications, and other alerts as well as easy access to study information and video visit capabilities for remote assessments - all to improve convenience and adherence to your protocol.

Ready to learn more?

Discover how Signant can support your current or upcoming colorectal cancer trials.

DOWNLOAD BROCHURE GET STARTED